home.social

#egfr — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #egfr, aggregated by home.social.

  1. AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

    WILMINGTON, Del., September 01, 2026–(BUSINESS WIRE)–AstraZeneca today announced the successful completion of the previously announced exclusive license agreement…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #0.8% #121 #1st #Dizal #DizalPharmaceuticalCo. #EGFR #FDA #Ltdfor #NCCN #nsclc #TheNewEnglandJournalofMedicine #TheUSFDA
    europesays.com/britain/115085/